Moderate

Epilepsy — chronic management & first unprovoked seizure (new-onset epilepsy, AED initiation)

Seizure / epilepsy (non-status) · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Recurrent unprovoked seizures or a first seizure with high recurrence risk. Distinct from status epilepticus (covered) — this entry is about work-up after a first seizure and starting/maintaining anti-seizure medication (ASM). Epilepsy is defined as >=2 unprovoked seizures >24h apart, OR one unprovoked seizure with >=60% recurrence risk (epileptiform EEG, structural lesion, nocturnal seizure).

Red flags

  • Focal neurological deficit, papilloedema or headache — structural lesion / raised ICP
  • Seizure in pregnancy >20 weeks — eclampsia until proven otherwise
  • Fever + seizure — CNS infection, needs LP
  • New focal seizures in older adult — stroke/tumour; in HIV/immunocompromised — toxoplasma, PML, abscess
  • Status epilepticus / recurrent seizures without recovery — escalate (see Status epilepticus)
  • Rash on lamotrigine/carbamazepine — stop, consider SJS/TEN / DRESS

Assessment

Differential diagnosis

  • Syncope (convulsive) — covered
  • Psychogenic non-epileptic seizure / functional seizure
  • Provoked seizure (hypoglycaemia, hyponatraemia, alcohol/BZD withdrawal, drugs, eclampsia, CNS infection)
  • TIA / transient global amnesia
  • Migraine with aura
  • Movement disorder / dystonia
  • Cardiac arrhythmia with cerebral hypoperfusion

Investigations

  • Capillary + lab glucose, U&E, Ca, Mg, Na (exclude provoked seizure)
  • ECG (QT, Brugada, heart block — syncope mimic)
  • Prolactin within 10-20 min can support generalised/complex seizure if raised (poor sensitivity) [verify local]
  • 12-lead + bloods; pregnancy test in women of childbearing age
  • Neuroimaging: MRI brain (preferred) for all first unprovoked seizures; non-contrast CT in ED if focal deficit, trauma, immunocompromise, anticoagulation, or no urgent MRI access
  • EEG (ideally within 24-72h, sleep-deprived if first normal) — supports diagnosis & classifies, does not exclude
  • LP only if suspected CNS infection / SAH
  • Alcohol & drug screen where relevant

Management

  • Confirm it was a seizure: eyewitness account, lateral tongue bite, post-ictal confusion, incontinence; distinguish from syncope & functional seizure
  • Exclude & correct provoked causes — a provoked seizure does NOT mean epilepsy and usually does not warrant long-term ASM
  • Classify seizure type (focal vs generalised) and epilepsy syndrome — drives ASM choice
  • Decide on ASM: generally NOT started after a single unprovoked seizure with normal work-up (low recurrence); DO consider after first seizure if epileptiform EEG, structural lesion, focal deficit, or nocturnal seizure (recurrence risk >60%)
  • Start monotherapy, titrate slowly to lowest effective dose; review adherence/triggers before adding/switching
  • Counsel: driving cessation and notify licensing authority (UK DVLA: 6 months off driving after first seizure if no high recurrence risk, 12 months if epilepsy diagnosed and seizure-free rules; India — local RTO rules [verify local]); avoid swimming alone, heights, operating machinery; SUDEP discussion
  • Women of childbearing potential: avoid valproate (teratogenic — MHRA/Pregnancy Prevention Programme); prefer lamotrigine/levetiracetam; high-dose folic acid 5 mg OD pre-conception
  • Arrange first-seizure clinic / neurology follow-up within 2 weeks

Drugs & doses

Focal seizures first-line monotherapy (NICE NG217): lamotrigine — start 25 mg PO OD x2 weeks, then 50 mg OD x2 weeks, then increase by 50-100 mg every 1-2 weeks; usual maintenance 100-400 mg/day in 1-2 divided doses [verify local dose]
OR levetiracetam — start 250 mg PO BD, increase by 250 mg BD every 1-2 weeks; usual 500-1500 mg BD (max 3000 mg/day) — watch behavioural/mood effects
Generalised tonic-clonic first-line: lamotrigine OR levetiracetam OR sodium valproate (valproate NOT in women/girls of childbearing potential unless PPP conditions met)
Sodium valproate (men / not childbearing potential) — start 300 mg PO BD, increase to 500-1000 mg BD; max 2000-2500 mg/day; monitor LFTs, FBC
Absence seizures: ethosuximide — start 250 mg PO OD-BD, titrate to 500-1500 mg/day (child: 10-15 mg/kg/day) [verify local dose]
Juvenile myoclonic epilepsy (not childbearing potential): valproate; alternatives levetiracetam, lamotrigine (lamotrigine may worsen myoclonus)
Carbamazepine (focal, 2nd-line) — start 100-200 mg PO OD-BD, titrate to 400-1200 mg/day in divided doses; enzyme inducer — many interactions, avoid in generalised/myoclonic (may worsen)
Folic acid 5 mg PO OD for women of childbearing potential on ASMs

Disposition

Most discharge from ED after first seizure once provoked causes excluded and patient at baseline; urgent (<2 week) first-seizure / neurology clinic + outpatient MRI & EEG. Admit if: abnormal neurology, failure to return to baseline, recurrent seizures, suspected symptomatic cause (tumour, infection, stroke), or unsafe social circumstances.

Complications & pitfalls

  • Recurrent seizures, injury, aspiration
  • SUDEP (sudden unexpected death in epilepsy)
  • ASM adverse effects: lamotrigine rash/SJS (slow titration critical), valproate hepatotoxicity/teratogenicity/weight gain, levetiracetam irritability/depression, carbamazepine hyponatraemia/marrow suppression
  • Drug interactions (enzyme inducers reduce contraceptive & DOAC efficacy)
  • Psychosocial: driving loss, employment, depression/anxiety

Exam pearls

  • NICE NG217 (updated 2025 for MHRA valproate advice): focal — lamotrigine or levetiracetam first-line; GTC — lamotrigine, levetiracetam or valproate (valproate not in childbearing potential); absence — ethosuximide
  • Do NOT start lifelong ASM for a clearly provoked seizure (hypoglycaemia, withdrawal, hyponatraemia) — treat the cause
  • Slow lamotrigine titration prevents SJS; valproate inhibits lamotrigine metabolism so halve lamotrigine dose if co-prescribed
  • Always address driving & SUDEP at first contact and document
  • Prolonged QT / Brugada on ECG points to convulsive syncope, not epilepsy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.